ยินดีต้อนรับกลับมา
เข้าร่วม CoinTime
เข้าสู่ระบบ email
สร้างบัญชี email
ตรวจสอบกล่องจดหมายของคุณ
AnaBios
About
AnaBios provides contract research services for biotechnology and pharmaceutical industries.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series Unknown
- Industries
- Biotechnology,Medical,Pharmaceutical
- Founded date
- Jan 1, 2009
- Number Of Employee
- 11 - 50
- Operating Status
- Active
AnaBios specializes in enabling human-focused drug discovery. As a CRO, AnaBios provides products and services for every stage of drug discovery. Through proprietary technology based on the use of human donor organs and tissues, it studies ex vivo human responses to drugs and further investigate the molecular and functional basis of relevant human physiology. Its research focuses primarily on the areas of high, unmet medical need, including cardiac disease and safety, pain, PKD kidney disease, and neurodegeneration. In partnership with Fortune 500 pharmaceutical companies, contract research organizations, and universities, the company's mission is to develop therapeutic advancements to help patients live longer, healthier, and more productive lives.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 1, 2015 | Series Unknown | — | 1 | — | — | Detail |
| Jan 1, 2014 | Series Unknown | — | 1 | — | — | Detail |
| Jan 1, 2013 | Series Unknown | — | 1 | — | — | Detail |
| Jan 1, 2012 | Series Unknown | — | 1 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Keiretsu Forum
|
— | Series Unknown |
